permeabilization solution (Multi Sciences (Lianke) Biotech Co Ltd)
Multi Sciences (Lianke) Biotech Co Ltd is a verified supplier 
Multi Sciences (Lianke) Biotech Co Ltd manufactures this product 
98
Structured Review
Multi Sciences (Lianke) Biotech Co Ltd
permeabilization solution
Permeabilization Solution, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 98/100, based on 1474 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/permeabilization+kit/Cell+cycle+staining+Kit/pm42172932-285-56-58
Average 98 stars, based on 1474 article reviews
Permeabilization Solution, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 98/100, based on 1474 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/permeabilization+kit/Cell+cycle+staining+Kit/pm42172932-285-56-58
Average 98 stars, based on 1474 article reviews
permeabilization solution - by Bioz Stars,
2026-10
98/100 stars
Images
Related Articles
other:Article Title: Novel autophagy-promoted cancer therapy: Discovery of matrine-based selective TBC1D2 inhibitors by drug-target complex purification. Article Snippet: Autophagy strategies have seen clinical or preclinical studies underway to combat cancer therapeutic resistance, but the on-target effects in normal tissues necessitate new selective approaches.. Based on the antitumor efficacy and low toxicity of matrine, a traditional Chinese medicine component, we designed and synthesized 24 matrine derivatives with higher in vitro activities.. Among these compounds, A1 demonstrated the highest activity and selectivity against the HeLa cell line, with a half maximal inhibitory concentration of 0.43 μM and a selective index of 3.5. Staining:Article Title: Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer. Article Snippet: .. Upon reaching 70–80% confluence, the cells were washed with DPBS, collected via trypsin digestion, and stained for cell cycle analysis with DNA staining and Article Title: The MTH1 inhibitor TH287 sensitized Castration-Resistant Prostate Cancer cells to ionizing radiation therapy. Article Snippet: .. After 72 h of incubation, the cells were harvested with trypsin, rinsed with chilled PBS, stained in 1 mL DNA staining solution and 10 μL Article Title: Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer Article Snippet: .. Upon reaching 70–80% confluence, the cells were washed with DPBS, collected via trypsin digestion, and stained for cell cycle analysis with DNA staining and Article Title: Oxidative stress-mediated impairment of human trophoblast cell proliferation by zinc pyrithione exposure Article Snippet: .. The pellet was resuspended in ice-cold PBS, followed by the addition of 1 mL DNA staining solution and 10 μL Article Title: Silencing of MAT2A inhibits gastric cancer cell proliferation, migration, and invasion through activation of the p53 pathway. Article Snippet: Objective This study aimed to evaluate the effects of MAT2A silencing on the proliferation, migration, and invasion of gastric cancer (GC) cells and to investigate the underlying molecular mechanisms.. Methods MAT2A expression in GC tissues and adjacent normal tissues was assessed using immunohistochemistry and western blotting.. Two GC cell lines with elevated MAT2A expression underwent gene silencing. Cell Cycle Assay:Article Title: Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer. Article Snippet: .. Upon reaching 70–80% confluence, the cells were washed with DPBS, collected via trypsin digestion, and stained for cell cycle analysis with DNA staining and Article Title: Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer Article Snippet: .. Upon reaching 70–80% confluence, the cells were washed with DPBS, collected via trypsin digestion, and stained for cell cycle analysis with DNA staining and Incubation:Article Title: The MTH1 inhibitor TH287 sensitized Castration-Resistant Prostate Cancer cells to ionizing radiation therapy. Article Snippet: .. After 72 h of incubation, the cells were harvested with trypsin, rinsed with chilled PBS, stained in 1 mL DNA staining solution and 10 μL Article Title: Discovery of WWZ-11-098: a rigid and selective CDK6 degrader. Article Snippet: Dysregulation of the cell cycle, a hallmark of cancer, frequently involves aberrant activation of cyclin D-CDK4/6 complexes.. Although dual-CDK4/6 inhibitors are effective in advanced hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, CDK6 is preferentially expressed and functionally upregulated in hematologic malignancies, making it a promising therapeutic target.. The high structural homology between CDK4 and CDK6, however, has made developing selective CDK6 inhibitors exceptionally difficult. Article Title: Silencing of MAT2A inhibits gastric cancer cell proliferation, migration, and invasion through activation of the p53 pathway. Article Snippet: Objective This study aimed to evaluate the effects of MAT2A silencing on the proliferation, migration, and invasion of gastric cancer (GC) cells and to investigate the underlying molecular mechanisms.. Methods MAT2A expression in GC tissues and adjacent normal tissues was assessed using immunohistochemistry and western blotting.. Two GC cell lines with elevated MAT2A expression underwent gene silencing. Flow Cytometry:Article Title: The MTH1 inhibitor TH287 sensitized Castration-Resistant Prostate Cancer cells to ionizing radiation therapy. Article Snippet: .. After 72 h of incubation, the cells were harvested with trypsin, rinsed with chilled PBS, stained in 1 mL DNA staining solution and 10 μL Article Title: Discovery of WWZ-11-098: a rigid and selective CDK6 degrader. Article Snippet: Dysregulation of the cell cycle, a hallmark of cancer, frequently involves aberrant activation of cyclin D-CDK4/6 complexes.. Although dual-CDK4/6 inhibitors are effective in advanced hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer, CDK6 is preferentially expressed and functionally upregulated in hematologic malignancies, making it a promising therapeutic target.. The high structural homology between CDK4 and CDK6, however, has made developing selective CDK6 inhibitors exceptionally difficult. |